Review




Structured Review

Biotechnology Information web-based alignment program blast2
Steady-state level and transactivation ability of mouse p53 phosphomutants. (A) The alignment of the C-termini of human (accession no. NP_000537) and mouse (accession no. NP_035770) p53 proteins was performed by the Web-based alignment program <t>BLAST2</t> (National Center for Biotechnology Information). Conserved residues are shown in the middle row between human and mouse p53 sequences. Serine residues at positions 375 and 378 for human p53, and at positions 373 and 375 for mouse p53, are indicated by boxes. (B) The S373 and S375 residues of mouse p53 were mutated to nonphosphorylatable alanine (A) residues or aspartic acid (D) that mimics phosphorylated residues, and were expressed in pCDNA or pBabe vectors. p53-/- MEFs were cotransfected with 1 µg of empty vector, wild-type or mutant mouse p53, and 0.2 µg of GFP-encoding plasmids, and the steady-state level of p53 phosphomutants was determined by Western blot analysis. (C) The transcriptional activity of the mouse phosphomutants was determined by luciferase assays, using mdm2 promoter-luciferase construct. Luciferase activity was determined by chemiluminescence and was normalized against β-galactosidase activity. The experiment was performed thrice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (D) Relative luciferase activity using the mdm2 promoter-luciferase construct was determined in mouse p53-transfected γ-irradiated (10 Gy) p53-/- MEFs, as described above. The experiment was performed twice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (E and F) Relative luciferase activity using p21 (E) and mdm2 promoter-luciferase constructs (F) together with human wild-type or phosphomutant IND constructs in p53-null H1299 cells. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (G and H) The expression of endogenous p53 target genes (bax, noxa, mdm2, and p21) in vector-transfected and p53-transfected p53-/- MEFs (G) or human H1299 cells (H) was determined by semiquantitative RT-PCR and normalized against endogenous gapdh RNA level as described previously.
Web Based Alignment Program Blast2, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+alignment+program+blast2/blast2/pmc01993853-120-67-74
Average 90 stars, based on 1 article reviews
web-based alignment program blast2 - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Phosphorylation at Carboxyl-Terminal S373 and S375 Residues and 14-3-3 Binding Are Not Required for Mouse p53 Function 1 "

Article Title: Phosphorylation at Carboxyl-Terminal S373 and S375 Residues and 14-3-3 Binding Are Not Required for Mouse p53 Function 1

Journal:

doi:

Steady-state level and transactivation ability of mouse p53 phosphomutants. (A) The alignment of the C-termini of human (accession no. NP_000537) and mouse (accession no. NP_035770) p53 proteins was performed by the Web-based alignment program BLAST2 (National Center for Biotechnology Information). Conserved residues are shown in the middle row between human and mouse p53 sequences. Serine residues at positions 375 and 378 for human p53, and at positions 373 and 375 for mouse p53, are indicated by boxes. (B) The S373 and S375 residues of mouse p53 were mutated to nonphosphorylatable alanine (A) residues or aspartic acid (D) that mimics phosphorylated residues, and were expressed in pCDNA or pBabe vectors. p53-/- MEFs were cotransfected with 1 µg of empty vector, wild-type or mutant mouse p53, and 0.2 µg of GFP-encoding plasmids, and the steady-state level of p53 phosphomutants was determined by Western blot analysis. (C) The transcriptional activity of the mouse phosphomutants was determined by luciferase assays, using mdm2 promoter-luciferase construct. Luciferase activity was determined by chemiluminescence and was normalized against β-galactosidase activity. The experiment was performed thrice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (D) Relative luciferase activity using the mdm2 promoter-luciferase construct was determined in mouse p53-transfected γ-irradiated (10 Gy) p53-/- MEFs, as described above. The experiment was performed twice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (E and F) Relative luciferase activity using p21 (E) and mdm2 promoter-luciferase constructs (F) together with human wild-type or phosphomutant IND constructs in p53-null H1299 cells. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (G and H) The expression of endogenous p53 target genes (bax, noxa, mdm2, and p21) in vector-transfected and p53-transfected p53-/- MEFs (G) or human H1299 cells (H) was determined by semiquantitative RT-PCR and normalized against endogenous gapdh RNA level as described previously.
Figure Legend Snippet: Steady-state level and transactivation ability of mouse p53 phosphomutants. (A) The alignment of the C-termini of human (accession no. NP_000537) and mouse (accession no. NP_035770) p53 proteins was performed by the Web-based alignment program BLAST2 (National Center for Biotechnology Information). Conserved residues are shown in the middle row between human and mouse p53 sequences. Serine residues at positions 375 and 378 for human p53, and at positions 373 and 375 for mouse p53, are indicated by boxes. (B) The S373 and S375 residues of mouse p53 were mutated to nonphosphorylatable alanine (A) residues or aspartic acid (D) that mimics phosphorylated residues, and were expressed in pCDNA or pBabe vectors. p53-/- MEFs were cotransfected with 1 µg of empty vector, wild-type or mutant mouse p53, and 0.2 µg of GFP-encoding plasmids, and the steady-state level of p53 phosphomutants was determined by Western blot analysis. (C) The transcriptional activity of the mouse phosphomutants was determined by luciferase assays, using mdm2 promoter-luciferase construct. Luciferase activity was determined by chemiluminescence and was normalized against β-galactosidase activity. The experiment was performed thrice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (D) Relative luciferase activity using the mdm2 promoter-luciferase construct was determined in mouse p53-transfected γ-irradiated (10 Gy) p53-/- MEFs, as described above. The experiment was performed twice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (E and F) Relative luciferase activity using p21 (E) and mdm2 promoter-luciferase constructs (F) together with human wild-type or phosphomutant IND constructs in p53-null H1299 cells. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (G and H) The expression of endogenous p53 target genes (bax, noxa, mdm2, and p21) in vector-transfected and p53-transfected p53-/- MEFs (G) or human H1299 cells (H) was determined by semiquantitative RT-PCR and normalized against endogenous gapdh RNA level as described previously.

Techniques Used: Plasmid Preparation, Mutagenesis, Western Blot, Activity Assay, Luciferase, Construct, Transfection, Irradiation, Expressing, Reverse Transcription Polymerase Chain Reaction

Related Articles

other:

Article Title: Area-wide insecticide resistance and endosymbiont incidence in the whitefly Bemisia tabaci MEAM1 (B biotype): A Neotropical context.
Article Snippet: Agriculture insecticides are used against insect pest species, but are able to change community structure in contaminated habitats, and also the genetic pool of exposed individuals.. In fact, the latter effect is a relevant tool to in situ biomonitoring of pollutant contamination and impact, besides its practical economic and management concerns.. This takes place because the emergence of individuals with resistance to insecticides is particularly frequent among insect pest species and usually enhances insecticide overuse and crop losses.

Article Title: Genome-Wide Identification and Stage-Specific Expression Profile Analysis Reveal the Function of Ribosomal Proteins for Oogenesis of Spodoptera litura
Article Snippet: Therefore, protein sequences of Rps from 6 insect species ( S. litura , B. mori , S. frugiperda , Helicoverpa armigera , Plutella xylostella and D. melanogaster ) were obtained from their genome databases in NCBI (National Center for Biotechnology Information) using Basic Local Alignment Search Tool (blast2.0) searched with Human Rps as the query sequences.

Article Title: Anti-surrogate light chain antibodies
Article Snippet: The NCBI-BLAST2 sequence comparison program may be downloaded from National Center for Biotechnology Information website, or otherwise obtained from the National Institute of Health, Bethesda, Md.

Article Title: Aptamer for NGF and use thereof
Article Snippet: Nucleotide sequence identity in the present specification can be calculated by, for example, aligning the two nucleotide sequences using the homology calculation algorithm NCBI BLAST-2 (National Center for Biotechnology Information Basic Local Alignment Search Tool) under the following conditions (gap open=5 penalties; gap extension=2 penalties; x_dropoff=50; expectation value=10; filtering=ON).

Software:

Article Title: Cells and methods for production of lysine and lysine-derived products
Article Snippet: .. Software for performing BLAST and BLAST2 analyses is publicly available through the National Center for Biotechnology Information (on the worldwide web at ncbi.nlm.nih.gov/). ..

Sequencing:

Article Title: A premature stop codon in BrFLC2 transcript results in early flowering in oilseed-type Brassica rapa plants.
Article Snippet: Key message Nonsense-mediated mRNA decay (NMD)-mediated degradation of BrFLC2 transcripts is the main cause of rapid flowering of oilseed-type B. rapa ‘LP08’ plants.. Abstract Many Brassica species require vernalization (long-term winter-like cooling) for transition to the reproductive stage.. In the past several decades, scientific efforts have been made to discern the molecular mechanisms underlying vernalization in many species.

Produced:

Article Title: A premature stop codon in BrFLC2 transcript results in early flowering in oilseed-type Brassica rapa plants.
Article Snippet: Key message Nonsense-mediated mRNA decay (NMD)-mediated degradation of BrFLC2 transcripts is the main cause of rapid flowering of oilseed-type B. rapa ‘LP08’ plants.. Abstract Many Brassica species require vernalization (long-term winter-like cooling) for transition to the reproductive stage.. In the past several decades, scientific efforts have been made to discern the molecular mechanisms underlying vernalization in many species.



Similar Products

90
Biotechnology Information web-based alignment program blast2
Steady-state level and transactivation ability of mouse p53 phosphomutants. (A) The alignment of the C-termini of human (accession no. NP_000537) and mouse (accession no. NP_035770) p53 proteins was performed by the Web-based alignment program <t>BLAST2</t> (National Center for Biotechnology Information). Conserved residues are shown in the middle row between human and mouse p53 sequences. Serine residues at positions 375 and 378 for human p53, and at positions 373 and 375 for mouse p53, are indicated by boxes. (B) The S373 and S375 residues of mouse p53 were mutated to nonphosphorylatable alanine (A) residues or aspartic acid (D) that mimics phosphorylated residues, and were expressed in pCDNA or pBabe vectors. p53-/- MEFs were cotransfected with 1 µg of empty vector, wild-type or mutant mouse p53, and 0.2 µg of GFP-encoding plasmids, and the steady-state level of p53 phosphomutants was determined by Western blot analysis. (C) The transcriptional activity of the mouse phosphomutants was determined by luciferase assays, using mdm2 promoter-luciferase construct. Luciferase activity was determined by chemiluminescence and was normalized against β-galactosidase activity. The experiment was performed thrice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (D) Relative luciferase activity using the mdm2 promoter-luciferase construct was determined in mouse p53-transfected γ-irradiated (10 Gy) p53-/- MEFs, as described above. The experiment was performed twice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (E and F) Relative luciferase activity using p21 (E) and mdm2 promoter-luciferase constructs (F) together with human wild-type or phosphomutant IND constructs in p53-null H1299 cells. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (G and H) The expression of endogenous p53 target genes (bax, noxa, mdm2, and p21) in vector-transfected and p53-transfected p53-/- MEFs (G) or human H1299 cells (H) was determined by semiquantitative RT-PCR and normalized against endogenous gapdh RNA level as described previously.
Web Based Alignment Program Blast2, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+alignment+program+blast2/blast2/pmc01993853-120-67-74
Average 90 stars, based on 1 article reviews
web-based alignment program blast2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Steady-state level and transactivation ability of mouse p53 phosphomutants. (A) The alignment of the C-termini of human (accession no. NP_000537) and mouse (accession no. NP_035770) p53 proteins was performed by the Web-based alignment program BLAST2 (National Center for Biotechnology Information). Conserved residues are shown in the middle row between human and mouse p53 sequences. Serine residues at positions 375 and 378 for human p53, and at positions 373 and 375 for mouse p53, are indicated by boxes. (B) The S373 and S375 residues of mouse p53 were mutated to nonphosphorylatable alanine (A) residues or aspartic acid (D) that mimics phosphorylated residues, and were expressed in pCDNA or pBabe vectors. p53-/- MEFs were cotransfected with 1 µg of empty vector, wild-type or mutant mouse p53, and 0.2 µg of GFP-encoding plasmids, and the steady-state level of p53 phosphomutants was determined by Western blot analysis. (C) The transcriptional activity of the mouse phosphomutants was determined by luciferase assays, using mdm2 promoter-luciferase construct. Luciferase activity was determined by chemiluminescence and was normalized against β-galactosidase activity. The experiment was performed thrice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (D) Relative luciferase activity using the mdm2 promoter-luciferase construct was determined in mouse p53-transfected γ-irradiated (10 Gy) p53-/- MEFs, as described above. The experiment was performed twice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (E and F) Relative luciferase activity using p21 (E) and mdm2 promoter-luciferase constructs (F) together with human wild-type or phosphomutant IND constructs in p53-null H1299 cells. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (G and H) The expression of endogenous p53 target genes (bax, noxa, mdm2, and p21) in vector-transfected and p53-transfected p53-/- MEFs (G) or human H1299 cells (H) was determined by semiquantitative RT-PCR and normalized against endogenous gapdh RNA level as described previously.

Journal:

Article Title: Phosphorylation at Carboxyl-Terminal S373 and S375 Residues and 14-3-3 Binding Are Not Required for Mouse p53 Function 1

doi:

Figure Lengend Snippet: Steady-state level and transactivation ability of mouse p53 phosphomutants. (A) The alignment of the C-termini of human (accession no. NP_000537) and mouse (accession no. NP_035770) p53 proteins was performed by the Web-based alignment program BLAST2 (National Center for Biotechnology Information). Conserved residues are shown in the middle row between human and mouse p53 sequences. Serine residues at positions 375 and 378 for human p53, and at positions 373 and 375 for mouse p53, are indicated by boxes. (B) The S373 and S375 residues of mouse p53 were mutated to nonphosphorylatable alanine (A) residues or aspartic acid (D) that mimics phosphorylated residues, and were expressed in pCDNA or pBabe vectors. p53-/- MEFs were cotransfected with 1 µg of empty vector, wild-type or mutant mouse p53, and 0.2 µg of GFP-encoding plasmids, and the steady-state level of p53 phosphomutants was determined by Western blot analysis. (C) The transcriptional activity of the mouse phosphomutants was determined by luciferase assays, using mdm2 promoter-luciferase construct. Luciferase activity was determined by chemiluminescence and was normalized against β-galactosidase activity. The experiment was performed thrice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (D) Relative luciferase activity using the mdm2 promoter-luciferase construct was determined in mouse p53-transfected γ-irradiated (10 Gy) p53-/- MEFs, as described above. The experiment was performed twice independently. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (E and F) Relative luciferase activity using p21 (E) and mdm2 promoter-luciferase constructs (F) together with human wild-type or phosphomutant IND constructs in p53-null H1299 cells. Data from one of the experiments, performed in duplicate, are presented as mean ± SD. (G and H) The expression of endogenous p53 target genes (bax, noxa, mdm2, and p21) in vector-transfected and p53-transfected p53-/- MEFs (G) or human H1299 cells (H) was determined by semiquantitative RT-PCR and normalized against endogenous gapdh RNA level as described previously.

Article Snippet: All subsequent experiments described were performed with p53 mutants based on both types of vectors, which showed similar and consistent results. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window caption a7 Steady-state level and transactivation ability of mouse p53 phosphomutants. (A) The alignment of the C-termini of human (accession no. NP_000537) and mouse (accession no. NP_035770) p53 proteins was performed by the Web-based alignment program BLAST2 (National Center for Biotechnology Information).

Techniques: Plasmid Preparation, Mutagenesis, Western Blot, Activity Assay, Luciferase, Construct, Transfection, Irradiation, Expressing, Reverse Transcription Polymerase Chain Reaction